<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Doxycycline</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00254</strong>&#160; (APRD00597)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved, investigational</td></tr><tr><th>Description</th><td><p>A synthetic tetracycline derivative with similar antimicrobial activity. Animal studies suggest that it may cause less tooth staining than other tetracyclines. It is used in some areas for the treatment of chloroquine-resistant falciparum malaria (malaria, falciparum). [PubChem]</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00254/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00254/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00254.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00254.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00254.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00254.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00254.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00254">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>6-alpha-deoxy-5-oxytetracycline</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>6&#945;-deoxy-5-oxytetracycline</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Salts</th><td class="table-container"><table class="inner">
  <thead>
    <tr>
      <th>Name/CAS</th>
      <th>Structure</th>
      <th>Properties</th>
      <th></th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>
          <strong>Doxycycline hyclate</strong>
          <div class="cas"></div>
        </td>
        <td><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DBSALT000896/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DBSALT000896/thumb.png"></a></td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
        <td><a class="btn btn-default btn-xs" href="/salts/DBSALT000896">DBSALT000896</a></td>
      </tr>
      <tr>
        <td>
          <strong>Doxycycline hydrochloride</strong>
          <div class="cas"></div>
        </td>
        <td><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DBSALT000897/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DBSALT000897/thumb.png"></a></td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
        <td><a class="btn btn-default btn-xs" href="/salts/DBSALT000897">DBSALT000897</a></td>
      </tr>
  </tbody>
</table></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Adoxa</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Alodox</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Atridox</td><td>Atrix</td></tr><tr><td>Doryx</td><td>Mayne</td></tr><tr><td>Doxy</td><td>Galpharma</td></tr><tr><td>Doxycin</td><td>Laboratoire Riva</td></tr><tr><td>Doxylin</td><td>Actavis</td></tr><tr><td>Jenacyclin</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Microdox</td><td>Micro Labs</td></tr><tr><td>Monodox</td><td>Watson</td></tr><tr><td>Morgidox</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>NicAzelDoxyKit</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Nu-Doxycycline</td><td>Nu-Pharm</td></tr><tr><td>Ocudox</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Oracea</td><td>Galderma</td></tr><tr><td>Periostat</td><td>Alliance</td></tr><tr><td>Supracyclin</td><td>Gr&#252;nenthal</td></tr><tr><td>Vibra-Tabs</td><td>Pfizer</td></tr><tr><td>Vibramycin</td><td>Pfizer</td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/anti-bacterial-agents">Anti-Bacterial Agents</a></li>
<li><a href="/mesh/antimalarials">Antimalarials</a></li>
<li><a href="/mesh/tetracyclines">Tetracyclines</a></li></ul></td></tr><tr><th>CAS number</th><td>564-25-0</td></tr><tr><th>Weight</th><td>Average: 444.4346<br>Monoisotopic: 444.153265754</td></tr><tr><th>Chemical Formula</th><td>C<sub>22</sub>H<sub>24</sub>N<sub>2</sub>O<sub>8</sub></td></tr><tr><th>InChI Key</th><td>JBIWCJUYHHGXTC-AKNGSSGZSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C22H24N2O8/c1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29/h4-7,10,14-15,17,25,27-29,32H,1-3H3,(H2,23,31)/t7-,10+,14+,15-,17-,22-/m0/s1</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide</div></td></tr><tr><th>SMILES</th><td><div class="wrap">[H][C@@]12[C@@H](C)C3=C(C(O)=CC=C3)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Benzenoids</td></tr><tr><th>Class</th><td>Acenes and Derivatives</td></tr><tr><th>Subclass</th><td>Naphthacenes</td></tr><tr><th>Direct parent</th><td>Naphthacenes</td></tr><tr><th>Alternative parents</th><td>Anthracenecarboxylic Acids and Derivatives; Anthraquinones; Tetralins; Phenols and Derivatives; Tertiary Alcohols; Polyols; Primary Carboxylic Acid Amides; Secondary Alcohols; Tertiary Amines; Ketones; Enolates; Carboxylic Acids; Enols; Polyamines</td></tr><tr><th>Substituents</th><td>anthraquinone; tetralin; phenol derivative; benzene; tertiary alcohol; polyol; tertiary amine; carboxamide group; ketone; primary carboxylic acid amide; secondary alcohol; polyamine; enol; carboxylic acid derivative; enolate; carboxylic acid; amine; alcohol; carbonyl group; organonitrogen compound</td></tr><tr><th>Classification description</th><td>This compound belongs to the naphthacenes. These are compounds containing a naphthacene moiety, which is a polyaromatic hydrocarbon made of four linearly fused benzene rings.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>Doxycycline is indicated for use in respiratory tract infections caused by Mycoplasma pneumoniae, Haemophilus influenzae, Streptococcus pneumoniae, Legionella spp., or Klebsiella spp. It is also used for prophylaxis of malaria. Doxycycline is indicated for a variety of bacterial infections, from Mycobacterium fortuitum and M. marinum, to susceptible E. coli and Brucella spp. It can be used as an alternative to treating plague, tetanus, Campylobacter fetus 
</td></tr><tr><th>Pharmacodynamics</th><td>Doxycycline, a long-acting tetracycline derived from oxytetracycline, is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with COPD, and adult periodontitis.</td></tr><tr><th>Mechanism of action</th><td>Doxycycline, like minocycline, is lipophilic and can pass through the lipid bilayer of bacteria. Doxycycline reversibly binds to the 30 S ribosomal subunits and possibly the 50S ribosomal subunit(s), blocking the binding of aminoacyl tRNA to the mRNA and inhibiting bacterial protein synthesis. Doxycycline prevents the normal function of the apicoplast of Plasmodium falciparum, a malaria causing organism. </td></tr><tr><th>Absorption</th><td>Completely absorbed following oral administration.</td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td>&gt;90%</td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Hepatic</p></td></tr><tr><th>Route of elimination</th><td>They are concentrated by the liver in the bile and excreted in the urine and feces at high concentrations in a biologically active form.</td></tr><tr><th>Half life</th><td>18-22 hours</td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td>Symptoms of overdose include anorexia, nausea, diarrhoea, glossitis, dysphagia, enterocolitis and inflammatory lesions (with monilial overgrowth) in the anogenital region, skin reactions such as maculopapular and erythematous rashes, exfoliative dermatitis, photosensitivity, hypersensitivity reactions such as urticaria, angioneurotic oedema, anaphylaxis, anaphyl-actoid purpura, pericarditis, and exacerbation of systemic lupus erythematosus, benign intracranial hypertension in adults disappearing on discontinuation of the medicine, haematologic abnormalities such as haemolytic anaemia, thrombocytopenia, neutropenia, and eosinophilia. LD<sub>50</sub>=262 mg/kg (I.P. in rat).</td></tr><tr><th>Affected organisms</th><td><ul><li>Enteric bacteria and other eubacteria</li></ul></td></tr><tr><th>Pathways</th><td class="data-table-container"><table class="table table-condensed table-striped" id="pathways"><thead><tr><th>Pathway</th><th>Category</th><th>SMPDB ID</th></tr></thead><tbody><tr><td>Doxycycline Action Pathway</td><td>Drug action</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00291?highlight%5Bcompounds%5D%5B%5D=DB00254&amp;highlight%5Bproteins%5D%5B%5D=DB00254">SMP00291</a></td></tr></tbody></table></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.85</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              -
        </td>
        <td>0.9881</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              -
        </td>
        <td>0.8706</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Substrate
        </td>
        <td>0.699</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8038</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8628</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9562</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.8008</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.9116</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Substrate</td>
        <td>0.6551</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9045</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9144</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9293</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9099</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8567</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.8086</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.9132
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.8632
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.9941
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.3159 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.9946
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.7466
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Mylan pharmaceuticals inc</li>
<li>Par pharmaceutical inc</li>
<li>Ranbaxy laboratories ltd</li>
<li>Sandoz inc</li>
<li>Watson laboratories inc</li>
<li>Watson pharmaceuticals inc</li>
<li>Galderma laboratories lp</li>
<li>Rachelle laboratories inc</li>
<li>Ivax pharmaceuticals inc sub teva pharmaceuticals usa</li>
<li>Pfizer laboratories div pfizer inc</li>
<li>Lannett holdings inc</li>
<li>Mutual pharmaceutical co inc</li>
<li>Pliva inc</li>
<li>Mayne pharma international faulding pharm</li>
<li>Warner chilcott bermuda ltd</li>
<li>Medicis pharmaceutical corp</li>
<li>Halsey drug co inc</li>
<li>Heather drug co inc</li>
<li>Interpharm inc</li>
<li>Private formulations inc</li>
<li>Ranbaxy pharmaceuticals inc</li>
<li>Superpharm corp</li>
<li>Warner chilcott div warner lambert co</li>
<li>West ward pharmaceutical corp</li>
<li>Teva pharmaceuticals usa inc</li>
<li>Collagenex inc</li>
<li>App pharmaceuticals llc</li>
<li>Baxter healthcare corp anesthesia and critical care</li>
<li>Bedford laboratories div ben venue laboratories inc</li>
<li>Tolmar inc</li>
<li>Corepharma llc</li>
<li>Larken laboratories inc</li>
<li>Mutual pharmacal co</li>
<li>Truxton inc</li>
<li>Vintage pharmaceuticals inc</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.actavis.com">Actavis Group</a></li>
<li><a href="http://www.acurapharm.com">Acura Pharmaceutical Technologies Inc.</a></li>
<li>Advanced Pharmaceutical Services Inc.</li>
<li>Advanced Vision Research</li>
<li><a href="http://www.aidarex.com">Aidarex Pharmacuticals LLC</a></li>
<li><a href="http://www.amerisourcebergen.com">Amerisource Health Services Corp.</a></li>
<li><a href="http://www.amneal.com">Amneal Pharmaceuticals</a></li>
<li><a href="http://www.apacepak.com">Apace Packaging</a></li>
<li><a href="http://www.apicalrx.com">Apical Pharmaceutical Corporation</a></li>
<li>Apotheca Inc.</li>
<li><a href="http://www.apothecon.nl">Apothecon</a></li>
<li><a href="http://www.apppharma.com">APP Pharmaceuticals</a></li>
<li><a href="http://www.aquapharm.com">Aqua Pharmaceuticals</a></li>
<li><a href="http://orders.a-smeds.com">A-S Medication Solutions LLC</a></li>
<li><a href="http://www.avidaspharma.com">Avidas Pharmaceuticals</a></li>
<li><a href="http://www.bedfordlabs.com">Bedford Labs</a></li>
<li>Belgomex Sprl</li>
<li><a href="http://www.benvenue.com">Ben Venue Laboratories Inc.</a></li>
<li>Bioglan Pharmaceuticals Co.</li>
<li><a href="http://www.bpipack.com">Blenheim Pharmacal</a></li>
<li>Block Drug Corp.</li>
<li><a href="http://www.blurx.us">Blu Pharmaceuticals LLC</a></li>
<li><a href="http://bryantranchprepack.com">Bryant Ranch Prepack</a></li>
<li>Bv Pharbita</li>
<li><a href="http://www.cardinal.com">Cardinal Health</a></li>
<li>Carlisle Laboratories Inc.</li>
<li><a href="http://www.catalent.com">Catalent Pharma Solutions</a></li>
<li>Collagenex Pharmaceuticals Inc.</li>
<li>Community Action Inc. Community Health Services</li>
<li>Comprehensive Consultant Services Inc.</li>
<li><a href="http://www.corepharma.com">Corepharma LLC</a></li>
<li>Coupler Enterprises Inc.</li>
<li><a href="http://www.darbydental.com">Darby Dental Supply Co. Inc.</a></li>
<li>Dept Health Central Pharmacy</li>
<li>DHHS Program Support Center Supply Service Center</li>
<li>Direct Dispensing Inc.</li>
<li><a href="http://www.drxdispensing.com">Dispensing Solutions</a></li>
<li><a href="http://www.dhscorp.com">Diversified Healthcare Services Inc.</a></li>
<li><a href="http://www.dsm.com">DSM Corp.</a></li>
<li>Eon Labs</li>
<li><a href="http://www.galderma.com">Galderma Laboratories</a></li>
<li><a href="http://www.gsms.us">Golden State Medical Supply Inc.</a></li>
<li>Goldline Laboratories Inc.</li>
<li><a href="http://www.hhlabs.com">H and H Laboratories</a></li>
<li><a href="http://hjharkinscompanyinc.com">H.J. Harkins Co. Inc.</a></li>
<li><a href="http://www.hikma.com">Hikma Pharmaceuticals</a></li>
<li><a href="http://www.innoviantpharmacy.com">Innoviant Pharmacy Inc.</a></li>
<li>Ivax Pharmaceuticals</li>
<li>Kaiser Foundation Hospital</li>
<li><a href="http://www.keltman.com">Keltman Pharmaceuticals Inc.</a></li>
<li>Lake Erie Medical and Surgical Supply</li>
<li><a href="http://www.lannett.com">Lannett Co. Inc.</a></li>
<li>Liberty Pharmaceuticals</li>
<li><a href="http://www.majorpharmaceuticals.com">Major Pharmaceuticals</a></li>
<li><a href="http://www.maynepharma.com">Mayne Pharma International Pty Ltd.</a></li>
<li><a href="http://www.mckesson.com">Mckesson Corp.</a></li>
<li><a href="http://www.medisca.com">Medisca Inc.</a></li>
<li><a href="http://www.medvantx.com">Medvantx Inc.</a></li>
<li><a href="http://www.msdh.state.ms.us">Mississippi State Dept Health</a></li>
<li><a href="http://www.unitdosesupply.com">Murfreesboro Pharmaceutical Nursing Supply</a></li>
<li>Mutual Pharmaceutical Co.</li>
<li><a href="http://www.mylan.com">Mylan</a></li>
<li><a href="http://www.nucarerx.com">Nucare Pharmaceuticals Inc.</a></li>
<li>Oclassen Pharmaceuticals Inc.</li>
<li><a href="http://www.ohmlabs.com">Ohm Laboratories Inc.</a></li>
<li><a href="http://www.palmettopharm.com">Palmetto Pharmaceuticals Inc.</a></li>
<li><a href="http://www.parpharm.com">Par Pharmaceuticals</a></li>
<li><a href="http://www.patheon.com">Patheon Inc.</a></li>
<li><a href="http://www.patientfirst.com">Patient First Corp.</a></li>
<li>PCA LLC</li>
<li><a href="http://www.pdrx.com">PD-Rx Pharmaceuticals Inc.</a></li>
<li><a href="http://www.pfizer.com">Pfizer Inc.</a></li>
<li><a href="http://www.pmrsinc.com">Pharmaceutical Manufacturing Research Services Inc.</a></li>
<li>Pharmaceutical Utilization Management Program VA Inc.</li>
<li><a href="http://www.pharmaderm.com">Pharmaderm</a></li>
<li><a href="http://www.pharmedixrx.com">Pharmedix</a></li>
<li><a href="http://www.pharmpakinc.com">Pharmpak Inc.</a></li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li><a href="http://www.pliva.com">Pliva Inc.</a></li>
<li><a href="http://www.preferredpharmaceuticals.com">Preferred Pharmaceuticals Inc.</a></li>
<li>Prepackage Specialists</li>
<li><a href="http://www.prepaksys.com">Prepak Systems Inc.</a></li>
<li><a href="http://www.worldoftest.com">Qualitest</a></li>
<li><a href="http://www.ranbaxy.com">Ranbaxy Laboratories</a></li>
<li><a href="http://www.rebelrx.com">Rebel Distributors Corp.</a></li>
<li>Redpharm Drug</li>
<li><a href="http://www.remedyrepack.com">Remedy Repack</a></li>
<li><a href="http://www.sandhillspackaging.com">Sandhills Packaging Inc.</a></li>
<li><a href="http://www.sandoz.ca">Sandoz</a></li>
<li><a href="http://www.southwoodhealthcare.com">Southwood Pharmaceuticals</a></li>
<li>St Mary's Medical Park Pharmacy</li>
<li><a href="http://statrxusa.exporterus.com">Stat Rx Usa</a></li>
<li><a href="http://www.tevapharm.com">Teva Pharmaceutical Industries Ltd.</a></li>
<li><a href="http://www.tolmar.com">Tolmar Inc.</a></li>
<li>Tya Pharmaceuticals</li>
<li><a href="http://www.universal-laboratories.co.uk">Universal Laboratories Inc.</a></li>
<li>Veratex Corp.</li>
<li><a href="http://www.versapharm.com">Versapharm Inc.</a></li>
<li><a href="http://ir.wcrx.com">Warner Chilcott Co. Inc.</a></li>
<li><a href="http://www.watson.com">Watson Pharmaceuticals</a></li>
<li>WC Pharmaceuticals</li>
<li><a href="http://www.west-ward.com">West-Ward Pharmaceuticals</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Capsule</td><td>Oral</td><td></td></tr><tr><td>Gel, metered</td><td>Periodontal</td><td></td></tr><tr><td>Tablet</td><td>Oral</td><td></td></tr></tbody></table></td></tr><tr><th>Prices</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="prices"><thead><tr><th>Unit description</th><th>Cost</th><th>Unit</th></tr></thead><tbody><tr><td>Vibramycin 25 mg/5ml Suspension 60ml Bottle</td><td>36.29USD</td><td>bottle</td></tr><tr><td>Adoxa pak 1-150 mg tablet</td><td>19.93USD</td><td>tablet</td></tr><tr><td>Doryx 150 mg Enteric Coated Tabs</td><td>17.51USD</td><td>tab</td></tr><tr><td>Doryx dr 150 mg tablet</td><td>16.83USD</td><td>tablet</td></tr><tr><td>Doxycycline hyc 100 mg vial</td><td>14.16USD</td><td>vial</td></tr><tr><td>Adoxa 100 mg tablet</td><td>13.86USD</td><td>tablet</td></tr><tr><td>Monodox 100 mg capsule</td><td>13.46USD</td><td>capsule</td></tr><tr><td>Adoxa 75 mg tablet</td><td>12.77USD</td><td>tablet</td></tr><tr><td>Oracea 40 mg Delayed Release Capsule</td><td>12.44USD</td><td>capsule</td></tr><tr><td>Oracea 40 mg capsule</td><td>11.96USD</td><td>capsule</td></tr><tr><td>Avidoxy 100 mg tablet</td><td>11.52USD</td><td>tablet</td></tr><tr><td>Monodox 75 mg capsule</td><td>11.02USD</td><td>capsule</td></tr><tr><td>Doryx 100 mg Enteric Coated Tabs</td><td>10.31USD</td><td>tab</td></tr><tr><td>Doryx dr 100 mg tablet</td><td>9.91USD</td><td>tablet</td></tr><tr><td>Adoxa pak 1-100 mg tablet</td><td>9.88USD</td><td>tablet</td></tr><tr><td>Doxycycline Monohydrate 150 mg tablet</td><td>9.51USD</td><td>tablet</td></tr><tr><td>Adoxa 50 mg tablet</td><td>9.29USD</td><td>tablet</td></tr><tr><td>Doxycycline mono 150 mg tablet</td><td>9.13USD</td><td>tablet</td></tr><tr><td>Doryx 75 mg Enteric Coated Tabs</td><td>8.76USD</td><td>tab</td></tr><tr><td>Doryx dr 75 mg tablet</td><td>8.42USD</td><td>tablet</td></tr><tr><td>Vibramycin 100 mg capsule</td><td>6.67USD</td><td>capsule</td></tr><tr><td>Vibra-tabs 100 mg tablet</td><td>6.67USD</td><td>tablet</td></tr><tr><td>Monodox 50 mg capsule</td><td>6.0USD</td><td>capsule</td></tr><tr><td>Doxycycline mono 100 mg tablet</td><td>5.98USD</td><td>tablet</td></tr><tr><td>Periostat 20 mg tablet</td><td>5.75USD</td><td>tablet</td></tr><tr><td>Doxycycline mono 75 mg tablet</td><td>5.74USD</td><td>tablet</td></tr><tr><td>Doxycycline Monohydrate 100 mg tablet</td><td>5.12USD</td><td>tablet</td></tr><tr><td>Doxycycline mono 50 mg tablet</td><td>4.17USD</td><td>tablet</td></tr><tr><td>Doxycycline Monohydrate 50 mg tablet</td><td>3.0USD</td><td>tablet</td></tr><tr><td>Doxycycline hyclate powder</td><td>2.56USD</td><td>g</td></tr><tr><td>Vibramycin 50 mg capsule</td><td>2.41USD</td><td>capsule</td></tr><tr><td>Doxycycline Monohydrate 100 mg capsule</td><td>2.22USD</td><td>capsule</td></tr><tr><td>Vibramycin 100 mg Capsule</td><td>1.91USD</td><td>capsule</td></tr><tr><td>Doxycycline Monohydrate 50 mg capsule</td><td>1.51USD</td><td>capsule</td></tr><tr><td>Doxycycline hyclate 100 mg tablet</td><td>1.28USD</td><td>tablet</td></tr><tr><td>Doxycycline hyclate 20 mg tablet</td><td>1.28USD</td><td>tablet</td></tr><tr><td>Doxycycline Hyclate 100 mg capsule</td><td>1.18USD</td><td>capsule</td></tr><tr><td>Doxycycline Hyclate 50 mg capsule</td><td>0.76USD</td><td>capsule</td></tr><tr><td>Vibramycin 50 mg/5ml Syrup</td><td>0.67USD</td><td>ml</td></tr><tr><td>Vibramycin 50 mg/5 ml syrup</td><td>0.64USD</td><td>ml</td></tr><tr><td>Apo-Doxy 100 mg Capsule</td><td>0.61USD</td><td>capsule</td></tr><tr><td>Apo-Doxy 100 mg Tablet</td><td>0.61USD</td><td>tablet</td></tr><tr><td>Doxycin 100 mg Capsule</td><td>0.61USD</td><td>capsule</td></tr><tr><td>Doxycin 100 mg Tablet</td><td>0.61USD</td><td>tablet</td></tr><tr><td>Novo-Doxylin 100 mg Capsule</td><td>0.61USD</td><td>capsule</td></tr><tr><td>Novo-Doxylin 100 mg Tablet</td><td>0.61USD</td><td>tablet</td></tr><tr><td>Nu-Doxycycline 100 mg Capsule</td><td>0.61USD</td><td>capsule</td></tr><tr><td>Pms-Doxycycline 100 mg Capsule</td><td>0.61USD</td><td>capsule</td></tr><tr><td>Pms-Doxycycline 100 mg Tablet</td><td>0.61USD</td><td>tablet</td></tr></tbody></table><div class="alert alert-warning clearfix">DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.</div></td></tr><tr><th>Patents</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="patents"><thead><tr><th>Country</th><th>Patent Number</th><th>Approved</th><th>Expires (estimated)</th></tr></thead><tbody><tr><td>United States</td><td>7749532</td><td>2007-12-19</td><td>2027-12-19</td></tr><tr><td>United States</td><td>5789395</td><td>1996-08-30</td><td>2016-08-30</td></tr></tbody></table></td></tr><tr id="properties"><th class="divider" colspan="2">Properties</th></tr><tr><th>State</th><td>solid</td></tr><tr><th>Experimental Properties</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr><tr><td>melting point</td><td>201 &#176;C</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>water solubility</td><td>630 mg/L (at 25 &#176;C)</td><td>YALKOWSKY,SH &amp; DANNENFELSER,RM (1992)</td></tr><tr><td>logP</td><td>-0.02</td><td>SANGSTER (1994)</td></tr><tr><td>logS</td><td>-2.87</td><td>ADME Research, USCD</td></tr></table></td></tr><tr><th>Predicted Properties</th><td class="data-table-container"><table class="table table-condensed table-striped"><thead><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr></thead><tbody><tr><td>water solubility</td><td>6.30e-01 g/l</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>-0.72</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>-3.4</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#logp_logd">ChemAxon</a></td></tr><tr><td>logS</td><td>-2.9</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>pKa (strongest acidic)</td><td>-2.2</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>pKa (strongest basic)</td><td>7.75</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>physiological charge</td><td>-1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>hydrogen acceptor count</td><td>9</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>hydrogen donor count</td><td>6</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>polar surface area</td><td>181.62</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topolgical_surface">ChemAxon</a></td></tr><tr><td>rotatable bond count</td><td>2</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>refractivity</td><td>113.89</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#refractivity">ChemAxon</a></td></tr><tr><td>polarizability</td><td>42.88</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>number of rings</td><td>4</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>bioavailability</td><td>1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>rule of five</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Ghose filter</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Veber's rule</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>MDDR-like rule</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="references"><th class="divider" colspan="2">References</th></tr><tr><th>Synthesis Reference</th><td><span class="citations"><p>Dai-Wu Seol, &#8220;<span class="caps">DNA</span> cassette for the production of secretable recombinant trimeric <span class="caps">TRAIL</span> proteins, tetracycline/ doxycycline-inducible adeno-associated virus vector, their combination and use in gene therapy.&#8221; U.S. Patent US20020128438, issued September 12, 2002.</p></span><a class="wishart-link-out" href="https://www.google.com/?tbm=pts#q=20020128438&amp;tbm=pts" target="_blank">US20020128438 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><th>General Reference</th><td><span class="citations"><ol>
	<li>Dahl EL, Shock JL, Shenai BR, Gut J, DeRisi JL, Rosenthal PJ: Tetracyclines specifically target the apicoplast of the malaria parasite Plasmodium falciparum. Antimicrob Agents Chemother. 2006 Sep;50(9):3124-31. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16940111">Pubmed</a></li>
	<li>Hoerauf A, Mand S, Fischer K, Kruppa T, Marfo-Debrekyei Y, Debrah AY, Pfarr KM, Adjei O, Buttner DW: Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production. Med Microbiol Immunol. 2003 Nov;192(4):211-6. Epub 2003 Mar 5. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12684759">Pubmed</a></li>
	<li>Taylor MJ, Makunde WH, McGarry HF, Turner JD, Mand S, Hoerauf A: Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial. Lancet. 2005 Jun 18-24;365(9477):2116-21. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15964448">Pubmed</a></li>
</ol></span></td></tr><tr><th>External Links</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Resource</th><th>Link</th></tr></thead><tbody><tr><td>KEGG Compound</td><td><a class="wishart-link-out" href="http://www.genome.jp/dbget-bin/www_bget?cpd:C06973" target="_blank">C06973 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PubChem Compound</td><td><a class="wishart-link-out" href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5281011" target="_blank">5281011 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PubChem Substance</td><td><a class="wishart-link-out" href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46506491" target="_blank">46506491 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChemSpider</td><td><a class="wishart-link-out" href="http://www.chemspider.com/Chemical-Structure.4444486.html" target="_blank">4444486 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>BindingDB</td><td><a class="wishart-link-out" href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50041429" target="_blank">50041429 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChEBI</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=50845" target="_blank">50845 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChEMBL</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1433" target="_blank">CHEMBL1433 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Therapeutic Targets Database</td><td><a class="wishart-link-out" href="http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP001371" target="_blank">DAP001371 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PharmGKB</td><td><a class="wishart-link-out" href="http://www.pharmgkb.org/drug/PA449415" target="_blank">PA449415 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Drug Product Database</td><td><a class="wishart-link-out" href="http://205.193.93.51/dpdonline/searchRequest.do?din=742562" target="_blank">742562 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>RxList</td><td><a class="wishart-link-out" href="http://www.rxlist.com/cgi/generic/doxycyc.htm" target="_blank">http://www.rxlist.com/cgi/generic/doxycyc.htm <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Drugs.com</td><td><a class="wishart-link-out" href="http://www.drugs.com/doxycycline.html" target="_blank">http://www.drugs.com/doxycycline.html <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Wikipedia</td><td><a class="wishart-link-out" href="http://en.wikipedia.org/wiki/Doxycycline" target="_blank">Doxycycline <span class="glyphicon glyphicon-new-window"> </span></a></td></tr></tbody></table></td></tr><tr><th>ATC Codes</th><td>A01AB22<ul class="atc-drug-tree"><li><a href="/atc/A#A">A &#8212; ALIMENTARY TRACT AND METABOLISM</a></li><li><a href="/atc/A01#A01">A01 &#8212; STOMATOLOGICAL PREPARATIONS</a></li><li><a href="/atc/A01A#A01A">A01A &#8212; STOMATOLOGICAL PREPARATIONS</a></li><li><a href="/atc/A01AB#A01AB">A01AB &#8212; Antiinfectives and antiseptics for local oral treatment</a></li></ul>J01AA02<ul class="atc-drug-tree"><li><a href="/atc/J#J">J &#8212; ANTIINFECTIVES FOR SYSTEMIC USE</a></li><li><a href="/atc/J01#J01">J01 &#8212; ANTIBACTERIALS FOR SYSTEMIC USE</a></li><li><a href="/atc/J01A#J01A">J01A &#8212; TETRACYCLINES</a></li><li><a href="/atc/J01AA#J01AA">J01AA &#8212; Tetracyclines</a></li></ul></td></tr><tr><th>AHFS Codes</th><td><ul><li>08:12.24</li>
<li>52:04.04</li></ul></td></tr><tr><th>PDB Entries</th><td><ul><li><a class="wishart-link-out" href="http://www.rcsb.org/pdb/explore.do?structureId=1P87" target="_blank">1P87 <span class="glyphicon glyphicon-new-window"> </span></a></li></ul></td></tr><tr><th>FDA label</th><td><a href="/system/fda_labels/DB00254.pdf?1265922796">show</a>(48.1 KB)</td></tr><tr><th>MSDS</th><td><a href="/system/msds/DB00254.pdf?1265922736">show</a>(73.4 KB)</td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB01418">Acenocoumarol</a></td><td>The tetracycline, doxycycline, may increase the anticoagulant effect of acenocoumarol.</td></tr><tr><td><a href="/drugs/DB00459">Acitretin</a></td><td>Increased risk of intracranial hypertension</td></tr><tr><td><a href="/drugs/DB01370">Aluminium</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB01351">Amobarbital</a></td><td>The anticonvulsant, amobarbital, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB01060">Amoxicillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00415">Ampicillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01125">Anisindione</a></td><td>The tetracycline, doxycycline, may increase the anticoagulant effect of anisindione.</td></tr><tr><td><a href="/drugs/DB01352">Aprobarbital</a></td><td>The anticonvulsant, aprobarbital, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB01574">Attapulgite</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB01061">Azlocillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00355">Aztreonam</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01602">Bacampicillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01053">Benzylpenicillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00307">Bexarotene</a></td><td>Tetracycline derivatives like doxycycline may enhance the adverse/toxic effect of Retinoic Acid Derivatives. Due to the risk of developing pseudotumor cerebri (also known as intracranial hypertension), avoid this combination of drugs if possible. If used concomitantly, monitor for evidence of this interaction (eg, dizziness, diplopia, headache).  </td></tr><tr><td><a href="/drugs/DB00237">Butabarbital</a></td><td>The anticonvulsant, butabarbital, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB00241">Butalbital</a></td><td>The anticonvulsant, butalbital, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB01353">Butethal</a></td><td>The anticonvulsant, butethal, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB01373">Calcium</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00258">Calcium Acetate</a></td><td>Calcium salts such as calcium acetate may decrease the serum concentration of tetracycline derivatives such as doxycycline. In general, the coadministration of oral calcium salts and oral tetracycline derivatives should be avoided. Interactions may be able to be minimized by administering oral calcium preparations several hours before or after the dose of the oral tetracycline derivatives. Even with dose separation, therapy may still be compromised. Monitor for decreased therapeutic effect of oral tetracycline derivatives. </td></tr><tr><td><a href="/drugs/DB01164">Calcium Chloride</a></td><td>Calcium salts such as calcium chloride may decrease the serum concentration of tetracycline derivatives such as doxycycline. In general, the coadministration of oral calcium salts and oral tetracycline derivatives should be avoided. Interactions may be able to be minimized by administering oral calcium preparations several hours before or after the dose of the oral tetracycline derivatives. Even with dose separation, therapy may still be compromised. Monitor for decreased therapeutic effect of oral tetracycline derivatives. </td></tr><tr><td><a href="/drugs/DB00564">Carbamazepine</a></td><td>The anticonvulsant, carbamazepine, may decrease the therapeutic effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB00578">Carbenicillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00766">Clavulanate</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01147">Cloxacillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00930">Colesevelam</a></td><td>Bile acid sequestrants such as colesevelam may decrease the absorption of Tetracycline Derivatives. Monitor for decreased therapeutic effects of tetracycline derivatives if coadministered with a bile acid sequestrant. If these agents are used concomitantly, separate doses 2 or more hours to minimize the interaction. The manufacturer of colesevelam suggests that drugs should be administered at least 1 hour before or 4 hours after colesevelam.</td></tr><tr><td><a href="/drugs/DB01000">Cyclacillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00485">Dicloxacillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00266">Dicoumarol</a></td><td>The tetracycline, doxycycline, may increase the anticoagulant effect of dicumarol.</td></tr><tr><td><a href="/drugs/DB01341">Dihydroquinidine barbiturate</a></td><td>The anticonvulsant, dihydroquinidine barbiturate, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB00977">Ethinyl Estradiol</a></td><td>Doxycycline may decrease the contraceptive effect of ethinyl estradiol.</td></tr><tr><td><a href="/drugs/DB00754">Ethotoin</a></td><td>The anticonvulsant, ethotoin, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB00926">Etretinate</a></td><td>Increased risk of intracranial hypertension</td></tr><tr><td><a href="/drugs/DB00301">Flucloxacillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01320">Fosphenytoin</a></td><td>The anticonvulsant, fosphenytoin, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB01354">Heptabarbital</a></td><td>The anticonvulsant, heptabarbital, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB00739">Hetacillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01355">Hexobarbital</a></td><td>The anticonvulsant, hexobarbital, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB01592">Iron</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00893">Iron Dextran</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00982">Isotretinoin</a></td><td>Increased risk of intracranial hypertension</td></tr><tr><td><a href="/drugs/DB01378">Magnesium</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB01377">Magnesium oxide</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00532">Mephenytoin</a></td><td>The anticonvulsant, mephenytoin, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB01357">Mestranol</a></td><td>This anti-infectious agent could decrease the effect of the oral contraceptive</td></tr><tr><td><a href="/drugs/DB00474">Methohexital</a></td><td>The anticonvulsant, methohexital, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB00563">Methotrexate</a></td><td>The tetracycline, doxycycline, may increase methotrexate toxicity.</td></tr><tr><td><a href="/drugs/DB00849">Methylphenobarbital</a></td><td>The anticonvulsant, methylphenobarbital, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB01603">Meticillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00948">Mezlocillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00607">Nafcillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00713">Oxacillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00417">Penicillin V</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00312">Pentobarbital</a></td><td>The anticonvulsant, pentobarbital, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB01174">Phenobarbital</a></td><td>The anticonvulsant, phenobarbital, may decrease the therapeutic effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB00252">Phenytoin</a></td><td>The anticonvulsant, phenytoin, may decrease the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB00319">Piperacillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01604">Pivampicillin</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB01605">Pivmecillinam</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00794">Primidone</a></td><td>The anticonvulsant, primidone, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB01346">Quinidine barbiturate</a></td><td>The anticonvulsant, quinidine barbiturate, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB00615">Rifabutin</a></td><td>The rifamycin decreases the effect of doxycycline</td></tr><tr><td><a href="/drugs/DB01045">Rifampicin</a></td><td>The rifamycin decreases the effect of doxycycline</td></tr><tr><td><a href="/drugs/DB00418">Secobarbital</a></td><td>The anticonvulsant , secobarbital, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB00306">Talbutal</a></td><td>The anticonvulsant, talbutal, decreases the effect of doxycycline.</td></tr><tr><td><a href="/drugs/DB00706">Tamsulosin</a></td><td>Doxycycline, a CYP3A4 inhibitor, may decrease the metabolism and clearance of Tamsulosin, a CYP3A4 substrate. Monitor for changes in therapeutic/adverse effects of Tamsulosin if Doxycycline is initiated, discontinued, or dose changed.</td></tr><tr><td><a href="/drugs/DB01606">Tazobactam</a></td><td>Possible antagonism of action</td></tr><tr><td><a href="/drugs/DB00599">Thiopental</a></td><td>Thiopental may decrease the serum levels of Doxycycline. A reduction in antimicrobial effects may occur. An alternative antibiotic may be considered. </td></tr><tr><td><a href="/drugs/DB01607">Ticarcillin</a></td><td>Doxycycline may reduce the effect of Ticarcillin by inhibiting bacterial growth. Ticarcillin exerts its effects on actively growing bacteria. To achieve synergism, Ticarcillin should be administered at least 2 hours prior to using Doxycycline.</td></tr><tr><td><a href="/drugs/DB01036">Tolterodine</a></td><td>Doxycycline may decrease the metabolism and clearance of Tolterodine. Adjust Tolterodine dose and monitor for efficacy and toxicity.</td></tr><tr><td><a href="/drugs/DB00755">Tretinoin</a></td><td>Doxycycline may increase the adverse effects of oral Tretinoin. Increase risk of pseudotumour cerebri. Concurrent therapy should be avoided.</td></tr><tr><td><a href="/drugs/DB00682">Warfarin</a></td><td>The tetracycline, doxycycline, may increase the anticoagulant effect of warfarin.</td></tr><tr><td><a href="/drugs/DB01593">Zinc</a></td><td>Formation of non-absorbable complexes</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><ul><li>Avoid alcohol.</li>
<li>Avoid milk, calcium containing dairy products, iron, antacids, or aluminum salts 2 hours before or 6 hours after using antacids while on this medication.</li>
<li>Take with a full glass of water Do not take calcium, aluminum, magnesium or Iron supplements within 2 hours of taking this medication.</li></ul></td></tr></tbody></table>